The FDA's December 18th guidance on Data Integrity and Compliance with Drug CGMP

The FDA's December 18th guidance on Data Integrity and Compliance with Drug CGMP

Brand: GMPWebSource

This document outlines the FDA's requirements for data integrity controls in the pharmaceutical industry.

  • The document details the FDA's requirements for data integrity controls, including record and metadata retention, audit trail reviews, backups, access controls, unique logins, and record storage locations.
Variants (1)
  • Default Title — 0.00 USD — In stock

AI Readiness

Good foundation, but some important product data is still missing.

61%